Chinook Therapeutics Announces Upcoming Data Presentations and Investor Conference…
Data on atrasentan to be presented in an oral presentation from the IgA nephropathy (IgAN) patient cohort of the phase 2 AFFINITY basket trialUpdated data to be presented from Cohort 1 of…